Valuation West Pharmaceutical Services, Inc.
Stocks
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
16:02:45 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 341.11 USD | +1.08% |
|
-3.46% | +23.98% |
| 08-26 | Boston Scientific hit by cyberattack, global operations affected | RE |
| 08-03 | Is everything under control? |  |
Company Valuation: West Pharmaceutical Services, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 34,744 | 17,424 | 26,053 | 23,723 | 19,795 | 24,006 | - | - |
| Change | - | -49.85% | 49.53% | -8.95% | -16.56% | 21.28% | - | - |
| Enterprise Value (EV) 1 | 34,744 | 16,738 | 25,406 | 23,441 | 19,206 | 23,503 | 22,967 | 22,547 |
| Change | - | -51.82% | 51.78% | -7.74% | -18.07% | 22.37% | -2.28% | -1.83% |
| P/E | 54.1x | 30.4x | 44.7x | 49x | 40.5x | 39.8x | 34.6x | 30.9x |
| PBR | 14.9x | 6.5x | 8.98x | 8.83x | 5.95x | 7.67x | 6.69x | 5.92x |
| PEG | - | -2.8x | 23.04x | -3.2x | 27.09x | 1.5x | 2.3x | 2.6x |
| Capitalization / Revenue | 12.3x | 6.04x | 8.83x | 8.2x | 6.44x | 7.11x | 6.69x | 6.23x |
| EV / Revenue | 12.3x | 5.8x | 8.61x | 8.1x | 6.25x | 6.96x | 6.4x | 5.85x |
| EV / EBITDA | 39.3x | 19x | 30.7x | 32.2x | 24.2x | 25x | 22.1x | 19.5x |
| EV / EBIT | 45.6x | 22x | 36.8x | 40.9x | 30.9x | 31x | 27.1x | 23.7x |
| EV / FCF | 105x | 38.1x | 61.3x | 84.8x | 41x | 54.6x | 40.5x | 31.1x |
| FCF Yield | 0.95% | 2.63% | 1.63% | 1.18% | 2.44% | 1.83% | 2.47% | 3.22% |
| Dividend per Share 2 | 0.69 | 0.74 | 0.78 | 0.82 | 0.85 | 0.9025 | 0.9729 | 1.121 |
| Rate of return | 0.15% | 0.31% | 0.22% | 0.25% | 0.31% | 0.26% | 0.29% | 0.33% |
| EPS 2 | 8.67 | 7.73 | 7.88 | 6.69 | 6.79 | 8.575 | 9.865 | 11.04 |
| Distribution rate | 7.96% | 9.57% | 9.9% | 12.3% | 12.5% | 10.5% | 9.86% | 10.2% |
| Net sales 1 | 2,832 | 2,887 | 2,950 | 2,893 | 3,074 | 3,375 | 3,587 | 3,854 |
| EBITDA 1 | 884.7 | 882.6 | 827.9 | 728.2 | 793.8 | 940.4 | 1,041 | 1,159 |
| EBIT 1 | 762.4 | 762 | 690.6 | 572.8 | 622.4 | 757.5 | 848.4 | 952.3 |
| Net income 1 | 661.8 | 585.9 | 593.4 | 492.7 | 493.7 | 614.5 | 701.2 | 778 |
| Net Debt 1 | - | -685.4 | -647.1 | -282 | -588.5 | -503.3 | -1,039 | -1,458 |
| Reference price 2 | 469.01 | 235.35 | 352.12 | 327.56 | 275.14 | 341.11 | 341.11 | 341.11 |
| Nbr of stocks (in thousands) | 74,080 | 74,033 | 73,990 | 72,422 | 71,943 | 70,376 | - | - |
| Announcement Date | 2/17/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 39.35x | 6.89x | 24.72x | 0.27% | 23.75B | |
| 32.26x | 4.34x | 16.7x | 2.29% | 195B | |
| 20.54x | 3.56x | 12.55x | 3.26% | 117B | |
| 17.63x | 0.2x | 12.88x | 0.74% | 61.45B | |
| 36.52x | 3.5x | 12x | 2.07% | 51.62B | |
| 29.92x | 7.37x | 19.04x | 1.34% | 51.03B | |
| 36.41x | 6.41x | 20.12x | -.--% | 34.27B | |
| 46.31x | 1.31x | 12.01x | 0.16% | 30.95B | |
| 19.61x | 3.03x | 11.04x | 1.46% | 23.41B | |
| 25.18x | 3.79x | 13.32x | 1.14% | 22.79B | |
| Average | 30.37x | 4.04x | 15.44x | 1.27% | 61.07B | |
| Weighted average by Cap. | 29.18x | 3.95x | 15.24x | 1.83% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- WST Stock
- Valuation West Pharmaceutical Services, Inc.
Select your edition
All financial news and data tailored to specific country editions
